retatrutide ly3437943 glp-1 gip glucagon (RETA) is one of the most promising investigational peptides in obesity research—but one important question deserves more attention: Can it affect birth control? Current evidence shows that receptor agonists slow Efficacy and safety of retatrutide,

At Park Avenue Endocrinology , we specialize in using GLP-1-based therapies to help patients with type 2 diabetes and obesity better manage their conditions

These insights should be interpreted with your healthcare provider as one piece of informationnot as a predictor of whether GLP-1 therapy will worsen gastroparesis in your specific case

Contact us today to learn more about how GLP-1 treatments can benefit you

He says losing the weight is still better for the back in the long run

AD Alzheimer's disease, PD Parkinson's disease, TNF- tumor necrosis factor-alpha, IL interleukin, PI3K phosphoinositide 3-kinase, Akt protein kinase B, PGC-1 peroxisome proliferator-activated receptor gamma coactivator 1-alpha, mTOR mechanistic target of rapamycin, CREB cAMP response element-binding protein, BDNF brain-derived neurotrophic factor Safety considerations and patient selection GLP-1 receptor agonists have a well-defined safety profile

Baseline gut microbiome impacts probiotics Bacillus licheniformis CMCC63516 in modulating the gut microbiome and preventing antibiotic-associated diarrhea: a double-blind, randomized controlled trial